Gary Fanger

Company: Rise Therapeutics

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Defining Innovative Clinical Strategies Conserving Spend 9:00 am

Join panelists to address securing funding strategies and perspectives on: What adaptive trial methodologies or other innovative approaches can biopharma look to incorporate for cost-efficiency which also guarantee rigor? What are the benefits and drawbacks of strategic partnerships as an approach to expertise sharing and accelerated progress in microbiome drug development? What criteria and benchmarks…Read more

day: Conference Day Two

Evolution of Novel Synthetic Biology-Derived Oral Immunotherapies 12:00 pm

Leveraging novel microbiome-regulated immune pathways Applications for synthetic biology engineering Improving immunotherapy Read more

day: Day One Track A (AM)